njdotcom Consultant’s alleged reaction to a promising cancer drug? Let’s cash in.
A New Jersey pharmaceutical consultant allegedly pocketed nearly half a million dollars by buying 150,000 shares after learning insider information, prosecutors say.
A New Jersey pharmaceutical consultant allegedly pocketed nearly half a million dollars by buying 150,000 shares after learning insider information, prosecutors say.